Works matching IS 0937941X AND DT 2021 AND VI 32 AND IP 3

Results: 21

In memory of Harry K Genant.

Published in:

2021

By:

Cooper, C.;
Halbout, P.;
Dawson-Hughes, B.;
Harvey, N.C.;
Kanis, J.A.;
Reginster, J.-Y.;
Rizzoli, R.

Publication type:

Obituary

Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture.

Published in:

2021

By:

Lane, N. E.;
Saag, K.;
O'Neill, T. J.;
Manion, M.;
Shah, R.;
Klause, U.;
Eastell, R.

Publication type:

Correction Notice

Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 495, doi. 10.1007/s00198-021-05825-6

By:

Osaki, M.;
Okuda, R.;
Saeki, Y.;
Okano, T.;
Tsuda, K.;
Nakamura, T.;
Morio, Y.;
Nagashima, H.;
Hagino, H.

Publication type:

Article

Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 575, doi. 10.1007/s00198-020-05806-1

By:

Winzenrieth, R.;
Ominsky, M.S.;
Wang, Y.;
Humbert, L.;
Weiss, R.J.

Publication type:

Article

Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 399, doi. 10.1007/s00198-020-05804-3

By:

Lems, W. F.;
Paccou, J.;
Zhang, J.;
Fuggle, N. R.;
Chandran, M.;
Harvey, N. C.;
Cooper, C.;
Javaid, K.;
Ferrari, S.;
Akesson, K. E.;
International Osteoporosis Foundation Fracture Working Group;
Akesson, K.E.;
Brandi, M.L.;
Chevalley, T.;
Fardellone, P.;
Goemaere, S.;
Harvey, N.C.;
Holzer, G.;
Javaid, M.K.;
Lems, W.

Publication type:

Article

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 595, doi. 10.1007/s00198-020-05802-5

By:

Hiligsmann, M.;
Maggi, S.;
Veronese, N.;
Sartori, L.;
Reginster, J.-Y.

Publication type:

Article

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 585, doi. 10.1007/s00198-020-05780-8

By:

Söreskog, E.;
Lindberg, I.;
Kanis, J.A.;
Åkesson, K.E.;
Willems, D.;
Lorentzon, M.;
Ström, O.;
Berling, P.;
Borgström, F.

Publication type:

Article

Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 437, doi. 10.1007/s00198-020-05735-z

By:

de Vries, B. C. S.;
Hegeman, J. H.;
Nijmeijer, W.;
Geerdink, J.;
Seifert, C.;
Groothuis-Oudshoorn, C. G. M.

Publication type:

Article

Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 565, doi. 10.1007/s00198-020-05732-2

By:

Zullo, A. R.;
Lee, Y.;
Lary, C.;
Daiello, L. A.;
Kiel, D. P.;
Berry, S. D.

Publication type:

Article

Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 529, doi. 10.1007/s00198-020-05724-2

By:

Lee, J.W.;
Min, C.;
Bang, C.H.;
Kwon, B.C.;
Choi, H.G.

Publication type:

Article

Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 413, doi. 10.1007/s00198-020-05704-6

By:

Rosenberg, D.;
Avni, T.;
Tsvetov, G.;
Gafter-Gvili, A.;
Diker-Cohen, T.

Publication type:

Article

Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 559, doi. 10.1007/s00198-020-05637-0

By:

Zhu, K.;
Zhang, J.;
Zhang, C.;
Zhao, Z.;
Gao, J.;
Li, X.;
Xia, X.;
Xu, X.;
Zhang, T.;
Guan, J.

Publication type:

Article

C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 425, doi. 10.1007/s00198-020-05623-6

By:

Mun, H.;
Liu, B.;
Pham, T. H. A.;
Wu, Q.

Publication type:

Article

Sleep duration and bone health measures in older men.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 515, doi. 10.1007/s00198-020-05619-2

By:

Swanson, C. M.;
Blatchford, P. J.;
Stone, K. L.;
Cauley, J. A.;
Lane, N. E.;
Rogers-Soeder, T. S.;
Redline, S.;
Bauer, D. C.;
Wright, K. P.;
Wierman, M. E.;
Kohrt, W. M.;
Orwoll, E. S.

Publication type:

Article

Incidence and circumstances of falls among middle-aged women: a cohort study.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 505, doi. 10.1007/s00198-020-05617-4

By:

Wang, M.;
Wu, F.;
Callisaya, M. L.;
Jones, G.;
Winzenberg, T.

Publication type:

Article

FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 467, doi. 10.1007/s00198-020-05616-5

By:

Sagalla, N.;
Colón-Emeric, C.;
Sloane, R.;
Lyles, K.;
Vognsen, J.;
Lee, R.

Publication type:

Article

Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 539, doi. 10.1007/s00198-020-05615-6

By:

Smith, L. M.;
Gallagher, J. C.

Publication type:

Article

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 473, doi. 10.1007/s00198-020-05611-w

By:

Vehmanen, L.;
Sievänen, H.;
Kellokumpu-Lehtinen, P.;
Nikander, R.;
Huovinen, R.;
Ruohola, J.;
Penttinen, H.M.;
Utriainen, M.;
Tokola, K.;
Blomqvist, C.;
Saarto, T.

Publication type:

Article

Functional electrical stimulation (FES)–assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 549, doi. 10.1007/s00198-020-05610-x

By:

Fang, Y.;
Morse, L.R.;
Nguyen, N.;
Battaglino, R.A.;
Goldstein, R.F.;
Troy, K.L.

Publication type:

Article

Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 483, doi. 10.1007/s00198-020-05591-x

By:

Hong, N.;
Siglinsky, E.;
Krueger, D.;
White, R.;
Kim, C. O.;
Kim, H. C.;
Yeom, Y.;
Binkley, N.;
Rhee, Y.;
Buehring, B.

Publication type:

Article

Exploring thoracic kyphosis and incident fracture from vertebral morphology with high-intensity exercise in middle-aged and older men with osteopenia and osteoporosis: a secondary analysis of the LIFTMOR-M trial.

Published in:

Osteoporosis International, 2021, v. 32, n. 3, p. 451, doi. 10.1007/s00198-020-05583-x

By:

Harding, A. T.;
Weeks, B. K.;
Lambert, C.;
Watson, S. L.;
Weis, L. J.;
Beck, B. R.

Publication type:

Article